by socium | May 8, 2019 | News
May 8, 2018 — Today, Socium Therapeutics announced that James E. Galen, PhD joined the company’s Scientific Advisory Board. Dr. Galen has focused on the construction of attenuated bacterial vaccines and their use as live vectors to deliver foreign antigens...
by socium | Oct 1, 2018 | News
October 1, 2018 — Socium Therapeutics has been selected to present at the BIO Investor Forum in San Francisco on October 18, 2018. Tim Salmon, CEO of Socium, commented, “I’m really excited to present in San Francisco. We have been meeting with many...
by socium | Aug 31, 2018 | News
August 31, 2018 — Today, Socium Therapeutics announced that Marcela F. Pasetti, PhD joined the company’s Scientific Advisory Board. Dr. Pasetti is a Professor at the University of Maryland School of Medicine in the Center for Vaccine Development. Dr....
by socium | Jul 12, 2018 | News
July 12, 2018 — Today, Socium Therapeutics announced that Anna Ferrari, MD has joined the company’s Scientific Advisory Board. Dr. Ferrari is a medical oncologist and clinical researcher dedicated to prostate cancer research. Her experience includes...
by socium | Jul 2, 2018 | News
July 2, 2018 — Today, Socium Therapeutics announced that Joachim Fensterle, PhD has joined the company’s Scientific Advisory Board. After receiving his PhD in immunology / infection biology from the Max Planck Institute for Infection Biology, Dr. Fensterle...
